Latest Breaking News On - Variant pharmaceuticals - Page 1 : comparemela.com

Focal Segmental Glomerulosclerosis (FSGS) Pipeline

Focal Segmental Glomerulosclerosis (FSGS) Pipeline
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

Retrophin incAbbvie incChemocentryx incVariant pharmaceuticals incTeva pharmaceutical industries ltdPfizer incGlobal focal segmental glomerulosclerosisVariant pharmaceuticalsTeva pharmaceutical industries

Focal Segmental Glomerulosclerosis (FSGS) Treatment Market

Focal Segmental Glomerulosclerosis (FSGS) Treatment Market
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

Variant pharmaceuticals incChemocentryx incRetrophin incFocal segmental glomerulosclerosisVariant pharmaceuticals

Focal Segmental Glomerulosclerosis (FSGS) Pipeline

Variant pharmaceuticals incPfizer incTeva pharmaceutical industries ltdAbbvie incRetrophin incChemocentryx incGlobal focal segmental glomerulosclerosisVariant pharmaceuticalsTeva pharmaceutical industries

ZyVersa Therapeutics Appoints Three New Board Members

New appointments bring expertise and proven leadership to ZyVersa to support advancement and development of VAR 200 for renal disease, and IC 100 .

Robertg finizioKatrin rupallaGregoryg freitagAmbrx biopharmaStephenc gloverDaniel oconnorJames sapirsteinEnochian biosciencesLectec corporationAxogen incPfizer incCompanies section governing boardContravir pharmaceuticalsPrnewsfoto variant pharmaceuticals incGilead sciencesPrnewswire zyversa therapeutics inc

ZyVersa Therapeutics Adds Two Esteemed Leaders in Nephrology to Its Renal Scientific Advisory Board to Support Clinical Advancement of Lead Renal Drug Candidate, VAR 200

Drs. Daniel C. Cattran and Fernando C. Fervenza join ZyVersa s distinguished group of Scientific AdvisorsVAR 200 is a phase 2a-ready cholesterol e.

United statesAlessia fornoniDanielc cattranSharong adlerFernandoc fervenzaDebbies gipsonStephenc gloverPabloa guzmanPablo guzmanMarlene haffnerDivision of nephrologyUniversity of torontoFounder of orphan solutionsProducts developmentDepartment of pediatrics at university michiganKatz family division of nephrology